MBX Biosciences sets IPO terms with plans to raise up to $136 million
MBX joins the IPO pipeline just days after two other biotechs set terms for their planned deals.
Trending
- Volunteers Cook 5,000 Thanksgiving Meals For Hurricane Victims In North Carolina
- Epstein’s ‘Pedophile Island’ Guest Reid Hoffman Planning to Flee America over Trump’s Win
- Is it safe to eat turkey this Thanksgiving amid bird flu outbreak? Here’s what experts say
- East Coast Marine drone squadron conducts first Reaper flight
- Justice Department to Whistleblower Exposing Trans Surgeries on Minors: 'Shut Up'
- Hallmark Channel Overtakes MSNBC, CNN In Ratings
- NHL Power Rankings: Jets continue to fly high, plus what each team is thankful for this season
- OpenAI’s Sora and other AI video makers look amazing in their demos – why won’t they let us try them?
- Why Israel and Hezbollah reached a ceasefire now − and what it means for Israel, Lebanon, Biden and Trump
- Former UK Prime Ministers Johnson, Truss, May and Brown Will Oppose Assisted Suicide Bill